Checkmate Pharmaceuticals CMPI
$ 10.5
0.0%
Quarterly report 2022-Q1
added 12-23-2023
Country |
USA |
IPO year |
2020 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Mr. Barry A. Labinger |
Employees in the company |
21 |
Shares |
21.6 M |
Market Cap[1] |
$ 231 M |
EBITDA (LTM) |
$ -64 M |
P/E (LTM) |
-3.56 |
P/S (LTM) |
- |
EPS (LTM) |
-2.95 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.